Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

The present invention is directed to methods of increasing muscular strength and muscular endurance with a combination of the administration of Asparagus racemosus to a subject and resistance training of the subject's body.

The present invention is directed to methods of increasing muscular strength and muscular endurance with a combination of the administration of Asparagus racemosus to a subject and resistance training of the subject's body.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

A composition of matter in the form of a base formula that is specifically formulated to be effective to overcome sleep issues. Optional additions to the base formula are disclosed to be effective in the improvement of specific sleep issues.

A composition of matter in the form of a base formula that is specifically formulated to be effective to overcome sleep issues. Optional additions to the base formula are disclosed to be effective in the improvement of specific sleep issues.